DERMATA THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
DERMATA THERAPEUTICS, INC. (DRMA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $12.07 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-11-15
- DERMATA THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was $12.18M, a 74376.35% increase year-over-year.
- DERMATA THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was $16.35K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2021-09-30 | $12.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $12.07M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$103.20K 10-Q · filed 2021-09-27 | ||
| 2020-09-30 | $16.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.24M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$1.26M 10-Q · filed 2021-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |